MONMOUTH JUNCTION, NJ--(MARKET WIRE)--Jul 30, 2007 -- MedaSorb Technologies Corporation (OTC BB:MSBT.OB - News) (Frankfurt:HQE.F - News) announced today that it will pursue the CE Mark for approval to market CytoSorb in Europe. The CE Mark is the regulatory pathway for approval of a medical device in the European Union.
